John Barstis

Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation

Chandra P. Belani, John Barstis, Michael C. Perry et al. · Journal of Clinical Oncology · 2003 · 205 citations

The reliability of fine‐needle aspiration biopsy as the initial diagnostic procedure for palpable masses

Barbara D. Florentine, Barry Staymates, Munif Rabadi et al. · Cancer · 2006 · 65 citations · Full text

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.

Sara A. Hurvitz, Mark D. Pegram, L. S. Lin et al. · Cancer Research · 2009 · 54 citations

First Line Treatment, Phase Ii Testing, Breast Oncology +12

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

Nu T. Lu, Jeffrey J. Raizer, Erwin P. Gabor et al. · Journal for ImmunoTherapy of Cancer · 2015 · 33 citations · Full text

Leptomeningeal Metastases, Intrathecal Trastuzumab, Breast Oncology +12

Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial

Suresh S. Ramalingam, John Barstis, Michael C. Perry et al. · Journal of Thoracic Oncology · 2006 · 23 citations

Three Different Schedules, Medicine, Cancer Management +8